Essential Neuromodulation

Höfundur: Jeffrey E. Arle (Útgáfa: 2)
Essential Neuromodulation

Kaup valmöguleikar

Essential Neuromodulation, Second Edition is a concise reference covering all of the basic principles of neuromodulation in a single affordable volume for neuroscientists, residents, fellows, bioengineers and basic clinical practitioners. This second edition expands on developments in the field since 2011, emphasizing essential observations from all of the important clinical phases involved in any neuromodulation: targeting, intraoperative assessment, programming, complications and complication avoidance.

As neuromodulation remains an exciting and rapidly advancing field, this information is critical for neurosurgeons, neurophysiologists, bioengineers and other proceduralists. Presents a comprehensive reference on the emerging field of neuromodulation that features chapters from leading physicians and researchers in the field Provides a cohesive presentation of neuromodulation technologies and interventions Contains 550 full-color pages that begin with an overview of the clinical phases involved in neuromodulation, the challenges facing therapies and intraoperative procedures, and innovative solutions for better patient care Emphasizes the fundamentals needed to embrace the neuromodulation field as a cohesive clinical entity Explores the use of electrical, chemical and mechanical interventions to heal and improve neurological deficits Covers the promise of neurostimulation for chronic pain, epilepsy, Parkinson’s disease, and other disorders and diseases Features developments in the field of neuromodulation since the first edition was published, including findings in lead, IPG and accessories.

Nánar um bókina

Útgefandi
Elsevier S & T
ISBN
9780128170014
Print ISBN
9780128170007
Format
ePub
Útgáfa
2
Höfundar
Jeffrey E. Arle
Tungumál
English
Útgefið
2022-07-11
Prent takmörkun á líftíma
10

Kaflar

  • Title of Book
  • Cover image
  • Title page
  • Table of Contents
  • Copyright
  • Contributors
  • Introduction
  • Part I: The neuromodulation approach
  • Chapter 1. The neuromodulation approach
  • Abstract
  • Introduction
  • History
  • Applications
  • Ethics
  • Cost
  • References
  • Part II: Regions of application
  • Chapter 2. Cerebral: surface
  • Abstract
  • Chapter 2
  • ICS versus NICS
  • Targeting
  • How does CS work?
  • Future developments
  • Chapter 2.1. Commentary on Chapter 2: cerebral: surface
  • Chapter 3. Cerebral—deep
  • Abstract
  • Introduction
  • The thalamus
  • Pain
  • Tremor
  • Epilepsy
  • Tourette's syndrome
  • Globus pallidus pars internus (GPi)
  • Parkinson's disease
  • Dystonia
  • Subthalamic nucleus (STN)
  • Pedunculopontine nucleus (PPN)
  • Deep cerebral target for psychiatric illness
  • Ventral capsule/ventral striatum (Vc/Vs)
  • Subgenual cingulate cortex (cg25)
  • Other deep cerebral targets for psychiatric illness
  • Hypothalamus
  • Conclusion
  • Chapter 3.1. Commentary on Chapter 3: cerebral–deep
  • Chapter 4. Spinal—extradural neuromodulation
  • Abstract
  • Introduction
  • Relevant anatomy
  • Indications
  • Evidence by stimulation paradigm
  • High-frequency stimulation
  • BurstDR stimulation
  • Dorsal root ganglion stimulation
  • Complications and pitfall avoidance
  • Conclusion
  • Further reading
  • Chapter 4.1. Commentary on Chapter 4: spinal—extradural
  • Chapter 5. Peripheral nerve stimulation
  • Abstract
  • Introduction
  • General principles of PNS for treatment of pain
  • Specific PNS applications
  • Autonomic nerve stimulation
  • Conclusion
  • Chapter 5.1. Commentary on Chapter 5: peripheral nerve stimulation
  • Part III: The neuromodulation therapy interface
  • Chapter 6. Waveforms and mechanisms in neuromodulation
  • Abstract
  • Introduction
  • Waveform shapes
  • Commercial applications
  • Mechanisms of action
  • Conclusions
  • Chapter 6.1. Commentary on Chapter 6: waveforms and mechanisms in neuromodulation
  • Chapter 7. The electrode—principles of the neural interface and materials
  • Abstract
  • Introduction
  • Physical basis of the electrode/electrolyte interface
  • Charge injection across the electrode–electrolyte interface during electrical stimulation
  • Charge injection for extracellular stimulation of excitable tissue
  • Mechanisms of damage
  • Design compromises for efficacious and safe electrical stimulation
  • Materials used as electrodes for charge injection and reversible charge storage capacity
  • Size and shape considerations
  • Chapter 7.1. Commentary on Chapter 7: the electrode—principles of the neural interface and materials
  • Targeted delivery of electrical energy
  • Optimizing neural activation
  • Injury produced by electrical stimulation
  • Constant current versus constant voltage stimulation
  • Chapter 8. Device materials, handling, and upgradability
  • Abstract
  • Introduction
  • Device construction
  • Lead system configuration and materials
  • Patient programmers and security
  • SCS lead complications
  • DBS lead complications
  • Safety considerations
  • Conclusions
  • Chapter 8.1. Commentary on Chapter 8: device materials, handling, and upgradability
  • Chapter 9. Electronics
  • Abstract
  • Introduction
  • Guiding design rationale
  • Neurostimulator design
  • Neurostimulation: pulse delivery
  • Neurostimulator architecture
  • Neurostimulator power
  • Neurostimulator communications
  • Conclusions
  • Chapter 9.1. Commentary on Chapter 9: electronics
  • Concluding remarks
  • Chapter 10. Power use in neurostimulators
  • Abstract
  • Overview
  • Introduction
  • Power and energy storage requirements
  • Batteries
  • Therapeutic power requirements
  • Methods of stimulation
  • Other energy sources
  • Performance limits of primary cell devices
  • Conclusions
  • Further reading
  • Chapter 10.1. Commentary on Chapter 10: power use in neurostimulators
  • Part IV: Placing neuromodulation in the human body
  • Chapter 11. Surgical techniques
  • Abstract
  • Introduction
  • Preoperative planning
  • Awake or asleep?
  • Lead insertion
  • Generator implantation
  • Conclusion
  • Chapter 11.1. Commentary on Chapter 11: surgical techniques
  • Chapter 12. Trials and their applicability
  • Introduction
  • Intrathecal infusion trials
  • Pump selection
  • Indications
  • Patient selection
  • Patient acceptance
  • Needle placement for intrathecal pump placement introduction
  • Preoperative preparation
  • Anesthesia
  • Procedure
  • Spinal cord stimulation trials
  • Operative technique
  • Conclusion
  • Selected readings
  • Chapter 12.1. Commentary on Chapter 12: trials and their applicability
  • Chapter 13A. Intraoperative physiology techniques to inform targeting
  • Abstract
  • Background
  • Description of neuromonitoring protocol
  • Interpretation of data
  • Intraoperative neuromonitoring for dorsal root ganglion stimulation
  • Uses of intraoperative neuromonitoring in determining physiologic differences in waveforms
  • Conclusion
  • Further reading
  • Chapter 13A.1. Commentary on Chapter 13A: intraoperative physiology techniques to inform targeting
  • Chapter 13. Limiting morbidity in neuromodulation
  • Abstract
  • Disclosures
  • Introduction
  • Preoperative considerations
  • Intraoperative considerations
  • Postoperative considerations
  • Conclusion
  • Chapter 13.1. Commentary on Chapter 13: limiting morbidity in neuromodulation
  • Patient selection
  • Infection/erosion
  • Neurologic deficit
  • CSF leak following intrathecal catheter placement
  • Part V: Troubleshooting and repair
  • Chapter 14. Intraoperative evaluation
  • Abstract
  • Introduction
  • Principles of assessment
  • Intraoperative testing
  • Testing methodology
  • Examples
  • Conclusion
  • Chapter 14.1. Commentary on Chapter 14: intraoperative evaluation
  • Chapter 15A. Troubleshooting of neuromodulatory devices: case examples
  • Abstract
  • Conflicts of interest
  • Introduction
  • Loss of therapy
  • Migration
  • Problems at generator site
  • Adverse stimulation effects
  • Erosion
  • Conclusion
  • Chapter 15A.1. Commentary on Chapter 15A: troubleshooting of neuromodulatory devices: case examples
  • Part VI: Postoperative management
  • Chapter 15. Programming—DBS programming
  • Abstract
  • Introduction
  • Overview
  • Process
  • Initial programming session
  • Follow-up
  • Maintenance
  • Alternative programming methods
  • Patient control
  • Conclusion
  • Further reading
  • Chapter 15.1. Commentary on Chapter 15: programming—DBS programming
  • Chapter 16. Programming—SCS
  • Abstract
  • Introduction
  • Technical considerations
  • Stimulation options
  • Minimizing energy usage
  • Patient response and preference
  • Conclusion
  • Chapter 16.1. Comments on Chapter 16: programming—SCS
  • Part VII: The end user
  • Chapter 17. Expectations and outcomes
  • Abstract
  • Deep brain stimulation for movement disorders
  • Epilepsy
  • Conclusions
  • References
  • Further reading
  • Chapter 18. Paradigm shifts and the future of neuromodulation
  • Abstract
  • Introduction
  • Paradigm shifts
  • Past paradigm shifts in neuromodulation: chronic opioid therapy and spinal cord stimulation for intractable pain
  • Past paradigm shifts in neuromodulation: spinal cord stimulation mechanism of action and SCS-induced paresthesias required for pain relief
  • Anticipated paradigm shifts in neuromodulation: the future of neuromodulation
  • Short term
  • Longer term
  • Paradigm shifts in neuromodulation
  • Neuromodulation for nondisease states
  • Neurostimulation: the way forward
  • References
  • Further reading
  • Appendix
  • NeuroPace
  • Nevro Corporation
  • LivaNova PLC
  • Saluda medical
  • Abbott laboratories
  • Medtronic
  • Nalu Medical
  • Boston Scientific
  • Index